165 related articles for article (PubMed ID: 4039850)
21. Reduced amounts of platelet 5-hydroxytryptamine in myeloproliferative disorders.
Okamoto S; Nishimura J; Motomura S; Ibayashi H
Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):142-5. PubMed ID: 7113610
[No Abstract] [Full Text] [Related]
22. [Platelet factor 3].
Isobe J
Rinsho Byori; 1987 Jun; Spec No 71():183-91. PubMed ID: 3306039
[No Abstract] [Full Text] [Related]
23. Qualitative disorders of platelets.
Zieve PD; Levin J
Major Probl Intern Med; 1976; 10():40-5. PubMed ID: 785114
[No Abstract] [Full Text] [Related]
24. Changes associated with platelet aging.
Ginsburg AD; Aster RH
Thromb Diath Haemorrh; 1972 Jul; 27(3):407-15. PubMed ID: 4662607
[No Abstract] [Full Text] [Related]
25. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
Tangün Y
Thromb Diath Haemorrh; 1971 Jun; 25(2):241-51. PubMed ID: 5284903
[No Abstract] [Full Text] [Related]
26. Platelet and plasma beta thromboglobulin in myeloproliferative syndromes and secondary thrombocytosis.
Boughton BJ; Allington MJ; King A
Br J Haematol; 1978 Sep; 40(1):125-32. PubMed ID: 81681
[TBL] [Abstract][Full Text] [Related]
27. [Coagulation disorders in diabetes mellitus].
Corsi L; Castellini G; Mignano C; Gherzi R
Arch Maragliano Patol Clin; 1979; 35(2):133-40. PubMed ID: 400621
[No Abstract] [Full Text] [Related]
28. Decreased platelet aggregation, Ca2+ and Mg2+ ATPase and platelet factor 3 activities in patients with Wilson disease.
Cohen AM; Brettbart H; Creter D; Levinsky H; Frydman M; Djaldetti M
Haematologica; 1984; 69(3):263-71. PubMed ID: 6147299
[No Abstract] [Full Text] [Related]
29. Platelet and plasma Factor 13 (fibrin-stabilizing factor).
Kiesselbach TH; Wagner RH
Thromb Diath Haemorrh Suppl; 1967; 26():155-65. PubMed ID: 4965104
[No Abstract] [Full Text] [Related]
30. On the existence of platelet receptors for factor V(a) and factor VIII(a).
Nesheim ME; Furmaniak-Kazmierczak E; Henin C; Côté G
Thromb Haemost; 1993 Jul; 70(1):80-6. PubMed ID: 8236120
[TBL] [Abstract][Full Text] [Related]
31. Platelet factor 3 in membranes and granules of human platelets.
Farská I; Pudlák P; Posedĕlová H
Acta Univ Carol Med Monogr; 1972; 53():141-6. PubMed ID: 4670726
[No Abstract] [Full Text] [Related]
32. Acquired platelet disorders.
Casari C; Bergmeier W
Thromb Res; 2016 May; 141 Suppl 2():S73-5. PubMed ID: 27207431
[TBL] [Abstract][Full Text] [Related]
33. Phospholipid determination in platelets, plasma and red cells of patients with chronic myeloproliferative disorders.
Cesar JM; Vecino A; Perez-Vaquero M; Navarro JL
Eur J Haematol; 1993 Apr; 50(4):234-6. PubMed ID: 8500606
[TBL] [Abstract][Full Text] [Related]
34. [Platelet factor 3 (PF3) and primary hemostasis: ditazol test].
Di Micco B; Boeri F; Pagliara E; Cinque MR; Messina MF; Marcacci M
Pediatria (Napoli); 1979 Jun; 87(2):237-43. PubMed ID: 44904
[No Abstract] [Full Text] [Related]
35. Recombinant activated factor VII for intractable bleeding post splenectomy in a patient with myeloproliferative disorder.
El Kinge AR; Mahfouz RA; Shamseddine AI; Taher AT
Blood Coagul Fibrinolysis; 2007 Sep; 18(6):577-9. PubMed ID: 17762536
[TBL] [Abstract][Full Text] [Related]
36. [Platelet factor 3 activity in myeloproliferative disorders as evaluation by a new simple method].
Inceman S; Tangün Y
Turk Tip Cemiy Mecm; 1970; 36(9):317-20. PubMed ID: 5524541
[No Abstract] [Full Text] [Related]
37. [Phospholipids and blood coagulation].
Kase F; Zitko M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(3):289-310. PubMed ID: 89981
[TBL] [Abstract][Full Text] [Related]
38. [Platelet factor 3 (P-F-3) in chronic renal failure. Effect of dialysis].
Lasierra Cirujeda J; Sánchez Casajus A; Vilades Juan E
Rev Clin Esp; 1980 Mar; 156(5):321-4. PubMed ID: 7384579
[No Abstract] [Full Text] [Related]
39. Platelet lipids and coagulation in plasma. I. Isolation and analysis.
Boggust WA
Ir J Med Sci; 1972; 141(7):128-35. PubMed ID: 4653623
[No Abstract] [Full Text] [Related]
40. Classification of thrombocytosis based on platelet function tests: correlation with hemorrhagic and thrombotic complications.
Zucker S; Mielke CH
J Lab Clin Med; 1972 Sep; 80(3):385-94. PubMed ID: 5055386
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
